Immunostimulatory capacity of DNA vaccine vectors in porcine PBMC: a specific role for CpG-motifs?

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Veterinary Immunology and Immunopathology

• Publication date

  2005-01-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VETIMM.2004.09.016PMID 15626469
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of CpG in DNA vaccines

  2009cited by this paper
• Restricted cytokine production from mouse peritoneal macrophages in culture in spite of extensive uptake of plasmid DNA

  2004cited by this paper
• Priming of piglets against enterotoxigenic E. coli F4 fimbriae by immunisation with FAEG DNA.

  2004cited by this paper
• CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization

  2003cited by this paper
• Biological activity of immunostimulatory CpG DNA motifs in domestic animals.

  2003cited by this paper
• Induction of protective immunity in pigs after immunisation with CpG oligodeoxynucleotides formulated in a lipid-based delivery system (Biphasix).

  2003cited by this paper
• Reduced faecal excretion of F4+-E coli by the intramuscular immunisation of suckling piglets by the addition of 1alpha,25-dihydroxyvitamin D3 or CpG-oligodeoxynucleotides.

  2003cited by this paper
• The DNA vaccine vector pcDNA3 induces IFN-alpha production in pigs.

  2002cited by this paper
• CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D.

  2002cited by this paper
• Bacterial CpG‐DNA and lipopolysaccharides activate Toll‐like receptors at distinct cellular compartments

  2002cited by this paper
• Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs.

  2002cited by this paper
• Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine.

  2002cited by this paper
• The DNA vaccine vector pcDNA3 induces IFN-α production in pigs

  2002cited by this paper
• DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice.

  2002cited by this paper
• Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors.

  2002cited by this paper
• Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo

  2002cited by this paper
• CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations.

  2002cited by this paper
• CpG oligodeoxynucleotides stimulate canine and feline immune cell proliferation.

  2002cited by this paper
• Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides.

  2001cited by this paper
• CpG Motif Identification for Veterinary and Laboratory Species Demonstrates That Sequence Recognition Is Highly Conserved

  2001cited by this paper
• Induction of Interleukin-6 and Interleukin-12 in Bovine B Lymphocytes, Monocytes, and Macrophages by a CpG Oligodeoxynucleotide (ODN 2059) Containing the GTCGTT Motif

  2001cited by this paper
• The plasmid pcDNA3 differentially induces production of interferon-alpha and interleukin-6 in cultures of porcine leukocytes.

  2001cited by this paper
• Comparative analysis of porcine cytokine production by mRNA and protein detection.

  2001cited by this paper
• Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

  2001cited by this paper
• Requirements for Effective Inhibition of Immunostimulatory CpG Motifs by Neutralizing Motifs

  2000cited by this paper
• A Toll-like receptor recognizes bacterial DNA

  2000cited by this paper
• Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells1

  2000cited by this paper
• CpG motifs for optimization of DNA vaccines.

  2000cited by this paper
• Deviation of the allergic IgE to an IgG response by gene immunotherapy.

  1999cited by this paper
• CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells.

  1999cited by this paper
• Mammalian granulocyte–macrophage colony‐stimulating factor and some CpG motifs have an effect on the immunogenicity of DNA and subunit vaccines in fish

  1999cited by this paper
• Induction of immune responses in pigs following oral administration of purified F4 fimbriae.

  1999cited by this paper
• Characterization of Plasmid DNA Binding and Uptake by Peritoneal Macrophages from Class A Scavenger Receptor Knockout Mice

  1999cited by this paper
• Targeting Improves the Efficacy of a DNA Vaccine against Corynebacterium pseudotuberculosis in Sheep

  1999cited by this paper
• Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus.

  1999cited by this paper
• Involvement of specific mechanism in plasmid DNA uptake by mouse peritoneal macrophages.

  1998cited by this paper
• The Influence of DNA Sequence on the Immunostimulatory Properties of Plasmid DNA Vectors

  1998cited by this paper
• CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen.

  1998cited by this paper
• Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.

  1998cited by this paper
• Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens.

  1998cited by this paper
• The role of CpG dinucleotides in DNA vaccines.

  1998cited by this paper
• The influence of base sequence on the immunological properties of defined oligonucleotides.

  1998cited by this paper
• DNA and a CpG Oligonucleotide Derived fromBabesia bovis Are Mitogenic for Bovine B Cells

  1998cited by this paper
• Gene vaccination: plasmid DNA is more than just a blueprint.

  1998cited by this paper
• Measles Virus DNA Vaccination: Antibody Isotype Is Determined by the Method of Immunization and by the Nature of both the Antigen and the Coimmunized Antigen

  1998cited by this paper
• CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species.

  1998cited by this paper
• Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV.

  1997cited by this paper
• A reverse transcription-polymerase chain reaction method to analyze porcine cytokine gene expression.

  1997cited by this paper
• CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity

  1997cited by this paper
• The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA.

  1997cited by this paper
• CpG‐containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvants

  1997cited by this paper
• Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants

  1997cited by this paper
• Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.

  1996cited by this paper
• CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.

  1996cited by this paper
• Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization

  1996cited by this paper
• CpG motifs in bacterial DNA trigger direct B-cell activation

  1995cited by this paper
• Lipofection of Synthetic Oligodeoxyribonucleotide Having a Palindromic Sequence of AACGTT to Murine Splenocytes Enhances Interferon Production and Natural Killer Activity

  1994cited by this paper

• Differential innate immune activation by four different CpG-ODNs in porcine and murine cells: Implications for vaccine design.

  2025cites this paper
• Recombinant plasmids containing CpG with porcine host defense peptides (PR‐39/pBD‐1) modulates the innate and adaptive intestinal immune responses (including maternal‐derived) in piglets

  2019cites this paper
• Nanoparticle formulation enhanced protective immunity provoked by PYGPI8p-transamidase related protein (PyTAM) DNA vaccine in Plasmodium yoelii malaria model.

  2014cites this paper
• DNA Plasmids for Non-viral Gene Therapy of Cancer

  2014cites this paper
• Three types of humanCpG motifs differentially modulate and augment immunogenicity of nonviral and viral repliconDNA vaccines as built‐in adjuvants

  2013cites this paper
• Ficolin Binds to the Glycoproteins Hemagglutinin and Neuraminidase and Inhibits Influenza A Virus Infection Both in vitro and in vivo

  2012cites this paper
• L-Ficolin Binds to the Glycoproteins Hemagglutinin and Neuraminidase and Inhibits Influenza A Virus Infection Both in vitro and in vivo

  2012cites this paper
• Residual DNA analysis in biologics development: Review of measurement and quantitation technologies and future directions

  2012cites this paper
• Oral immunization with F4 fimbriae and CpG formulated with carboxymethyl starch enhances F4-specific mucosal immune response and modulates Th1 and Th2 cytokines in weaned pigs.

  2012cites this paper
• Adjuvants and delivery systems in veterinary vaccinology: current state and future developments

  2011cites this paper
• A novel mitogen fusion protein against CD40+ cells with potent vaccine adjuvant properties.

  2010cites this paper
• Oral administration of beta-1,3/1,6-glucan Macrogard fails to enhance the mucosal immune response following oral F4 fimbrial immunisation in gnotobiotic pigs.

  2010cites this paper
• IL‐24 protects against Salmonella typhimurium infection by stimulating early neutrophil Th1 cytokine production, which in turn activates CD8+ T cells

  2009cites this paper
• Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS‐4, a novel pro‐apoptotic gene

  2009cites this paper
• An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs.

  2008cites this paper
• Comparison of immune responses in parenteral FaeG DNA primed pigs boosted orally with F4 protein or reimmunized with the DNA vaccine.

  2007cites this paper
• Optimization of an FaeG DNA vaccine in pigs

  2007cites this paper
• Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa.

  2006cites this paper
• Control of Trypanosoma cruzi infection and changes in T-cell populations induced by a therapeutic DNA vaccine in mice.

  2006cites this paper
• Immunostimulatory DNA – studies on the importance of secondary structure formation and CpG-motifs for IFN-α induction / inhibition using ODNs related to the genome of porcine circovirus type 2

  2006cites this paper
• Effect of CPG on swine neutrophils and use against Salmonella in pigs

  2005cites this paper